Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition.

[1]  Li Xing,et al.  Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804. , 2009, Biochemistry.

[2]  F. Lombardo,et al.  Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development. , 2006, Bioorganic & medicinal chemistry letters.

[3]  Dennis E Danley,et al.  Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase. , 2005, Journal of medicinal chemistry.

[4]  C. Dominguez,et al.  p38 Inhibitors: beyond pyridinylimidazoles , 2005 .

[5]  D. Zaller,et al.  Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity , 2003, Nature Structural Biology.

[6]  D. Zaller,et al.  Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity. , 2003 .

[7]  H. Seymour,et al.  Anti-TNF agents for rheumatoid arthritis. , 2001, British journal of clinical pharmacology.

[8]  U. Andersson,et al.  Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis. , 2000, Arthritis and rheumatism.

[9]  M L Foster,et al.  Potential of p38 inhibitors in the treatment of rheumatoid arthritis. , 2000, Drug news & perspectives.

[10]  E. Vasiliauskas,et al.  Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. , 1999, Gastroenterology.

[11]  P. Rutgeerts,et al.  Review article: efficacy of infliximab in Crohn’s disease — induction and maintenance of remission , 1999, Alimentary pharmacology & therapeutics.

[12]  D. Faulds,et al.  Etanercept: a review of its use in rheumatoid arthritis. , 1999, Drugs.

[13]  B. Karimi,et al.  Efficient Deoxygenation of Sulfoxides to Thioethers and Reductive Coupling of Sulfonyl Chlorides to Disulfides with Tungsten Hexachloride , 1999 .

[14]  M. Hirano,et al.  Alumina: an Efficient and Reusable Catalyst for the Oxidative Coupling of Thiols with DMSO , 1998 .

[15]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[16]  R. Maki,et al.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.

[17]  J. Dayer,et al.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[18]  Z. Kaminski.  2-Chloro-4,6-dimethoxy-1,3,5-triazine. A New Coupling Reagent for Peptide Synthesis , 1988 .